GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » PhenixFIN Corp (NAS:PFX) » Definitions » Sloan Ratio %
中文

PhenixFIN (PhenixFIN) Sloan Ratio %

: 0.00% (As of Dec. 2023)
View and export this data going back to 2011. Start your Free Trial

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

PhenixFIN's Sloan Ratio for the quarter that ended in Dec. 2023 was 0.00%.

As of Dec. 2023, PhenixFIN has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


PhenixFIN Sloan Ratio % Historical Data

The historical data trend for PhenixFIN's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhenixFIN Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PhenixFIN Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Asset Management subindustry, PhenixFIN's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhenixFIN Sloan Ratio % Distribution

For the Asset Management industry and Financial Services sector, PhenixFIN's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where PhenixFIN's Sloan Ratio % falls into.



PhenixFIN Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

PhenixFIN's Sloan Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Sloan Ratio=(Net Income (A: Sep. 2023 )-Cash Flow from Operations (A: Sep. 2023 )
-Cash Flow from Investing (A: Sep. 2023 ))/Total Assets (A: Sep. 2023 )
=(26.918--20.706
-0)/239.693
=19.87%

PhenixFIN's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(27.501--9.256
-0)/237.841
=15.45%

PhenixFIN's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 6.708 (Mar. 2023 ) + 8.917 (Jun. 2023 ) + 7.342 (Sep. 2023 ) + 4.534 (Dec. 2023 ) = $27.50 Mil.
PhenixFIN's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was -6.751 (Mar. 2023 ) + -4.775 (Jun. 2023 ) + -4.484 (Sep. 2023 ) + 6.754 (Dec. 2023 ) = $-9.26 Mil.
PhenixFIN's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was 0 (Mar. 2023 ) + 0 (Jun. 2023 ) + 0 (Sep. 2023 ) + 0 (Dec. 2023 ) = $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PhenixFIN  (NAS:PFX) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, PhenixFIN has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


PhenixFIN Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of PhenixFIN's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


PhenixFIN (PhenixFIN) Business Description

Traded in Other Exchanges
N/A
Address
445 Park Avenue, 10th Floor, New York, NY, USA, 10022
PhenixFIN Corp formerly Medley Capital Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.
Executives
Ellida Mcmillan officer: CFO & Chief Accounting Officer C/O ALCENTRA CAPITAL CORP., 200 PARK AVE, 7TH FL, NEW YORK NY 10166
David A Lorber director C/O FRONTFOUR CAPITAL GROUP LLC, 35 MASON STREET, 4TH FLOOR, GREENWICH CT 06830
Howard Amster director 23811 CHAGRIN BLVD # 200, BEACHWOOD OH 44122-5525
Arthur S Ainsberg director C/O ANGELO, GORDON & CO., L.P., 245 PARK AVENUE, 26TH FLOOR, NEW YORK NY 10167
Karin Hirtler-garvey director 112 W. 34TH STREET, NEW YORK NY 10120
Lowell W Robinson director 470 WEST END AVENUE, NEW YORK NY 10024
Fortress Investment Group Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, 46TH FLOOR, NEW YORK NY 10105
Drawbridge Special Opportunities Fund Lp 10 percent owner C/O FORTRESS INVESTMENT GROUP LLC, 1345 AVENUE OF THE AMERICAS, 46TH FLOOR, NEW YORK NY 10105
Fig Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, 46 FLOOR, NEW YORK NY 10105
Fortress Operating Entity I Lp 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Fig Corp. 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Db Med Investor I Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Drawbridge Special Opportunities Gp Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Drawbridge Special Opportunites Fund Ltd 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Fortress Principal Investment Holdings Iv Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105